-+ 0.00%
-+ 0.00%
-+ 0.00%

PDS BIOTECH UNVEILS UPDATED POSITIVE DATA FROM VERSATILE-002 TRIAL AND ADDITIONAL TRIALS EVALUATING VERSAMUNE® HPV TO TREAT HEAD AND NECK CANCERS AT THE 2025 AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) ANNUAL MEETING

Reuters·06/02/2025 12:00:02

Please log in to view news